GREENLIGHT CAPITAL INC

Q3 2017 13F Holdings Report, New Holdings, Stock Holdings

Notable people
David Einhorn
Signature - Title
Daniel Roitman - Chief Operating Officer
Location
New York, NY
Holdings as of
September 30, 2017
Value $
$413M
Num holdings
1
Date filed
11/21/2017, 10:00 AM
Description
Request for Confidential Treatment (11/14/2017): Confidential Treatment Expired on 11/21/2017. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q2 2017 - Aug 14, 2017
Next filing
Q4 2017 - Feb 14, 2018
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 11-14-2017 pursuant to a request for confidential treatment and for which confidential treatment expired on 11-21-2017.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Daniel Roitman Chief Operating Officer New York, New York 11/21/2017

Other Included Managers (2):

Num Name Location File Number
1 DME Advisors, LP New York, NY 028-13228
2 DME Capital Management, LP New York, NY 028-14000